Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya.
Prudhomme O'Meara, Wendy; Menya, Diana; Laktabai, Jeremiah; Platt, Alyssa; Saran, Indrani; Maffioli, Elisa; Kipkoech, Joseph; Mohanan, Manoj; Turner, Elizabeth L.
; 15(7): e1002607, 2018 07.
Artigo em Inglês | MEDLINE | ID: mdl-30016316
Subsidising artemisinin-based combination therapy in the private retail sector.
An assessment of the malaria-related knowledge and practices of Tanzania's drug retailers: exploring the impact of drug store accreditation.
The quest for universal access to effective malaria treatment: how can the AMFm contribute?
What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African countries under continuation of the private sector co-payment mechanism.
Too much to ask.
Donor support for quality assurance and pharmacovigilance of anti-malarials in malaria-endemic countries.
[Medical Costs on Malaria in Henan Province and Analysis of the Influential Factors].
Economics of malaria prevention in US travelers to West Africa.
Ongoing challenges in the management of malaria.
Public health: Death at the doorstep.